Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.29 0.26 0.94 13.32 10.19
Fund with Sales Charge (%) (POP) -17.29 0.26 0.94 13.32 10.19
Quarter EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.29 0.26 0.94 13.32 10.19
Fund with Sales Charge (%) (POP) -17.29 0.26 0.94 13.32 10.19
NASDAQ Biotechnology Index (%) -18.45 1.10 1.81 14.19 10.87
S&P 500 Index (%) 4.25 13.40 10.84 13.24 7.48

Calendar Year Returns

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund without Sales Charge (%) (NAV) -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64 11.93
Fund with Sales Charge (%) (POP) -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64 11.93
NASDAQ Biotechnology Index (%) -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25 15.84
S&P 500 Index (%) -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06 26.46

Cumulative Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 6.41 -17.29 0.80 4.81 249.14 749.53
Fund with Sales Charge (%) (POP) 6.41 -17.29 0.80 4.81 249.14 749.53
Quarter EndAs of 09/30/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 6.41 -17.29 0.80 4.81 249.14 749.53
Fund with Sales Charge (%) (POP) 6.41 -17.29 0.80 4.81 249.14 749.53
NASDAQ Biotechnology Index (%) 2.76 -18.45 3.32 9.39 276.85 872.33
S&P 500 Index (%) 20.55 4.25 45.80 67.27 246.74 390.39

After-Tax Average Annual Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.19 -0.72 -0.39 12.11
Fund without Sales Charge (%) (NAV) After Shares Sold -10.02 0.02 0.47 10.90
Fund with Sales Charge (%) (POP) Before Shares Sold -18.19 -0.72 -0.39 12.11
Fund with Sales Charge (%) (POP) After Shares Sold -10.02 0.02 0.47 10.90
Quarter EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.19 -0.72 -0.39 12.11
Fund without Sales Charge (%) (NAV) After Shares Sold -10.02 0.02 0.47 10.90
Fund with Sales Charge (%) (POP) Before Shares Sold -18.19 -0.72 -0.39 12.11
Fund with Sales Charge (%) (POP) After Shares Sold -10.02 0.02 0.47 10.90

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.79%
Net Expense Ratio [further-information] 0.77%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 10/31/2019 Updated Monthly, based on a 3-year period

Beta 1.08
Sharpe Ratio 0.28
Standard Deviation 22.40

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index